Swing Therapeutics Achieved 97% Patient Compliance with ePRO

  • Success Story
  • DCT, eCOA / ePRO

Download Now

Swing Therapeutics leveraged Medrio ePRO in a proof-of-concept for a decentralized hybrid study. Electronic Patient-Reported Outcomes (ePRO) technology was used to assess the results of varying digital therapies and the feasibility of conducting a largely virtual clinical study in a fibromyalgia population.

Subscribe to our mailing list

Sign up to have our latest insights delivered to your inbox.

Related Resources

  • CDMS / EDC, eCOA / ePRO, RTSM
  • Case Study
How Hinge Bio Runs Phase I Trials With Medrio EDC, ePRO and RTSM
  • CDMS / EDC, eCOA / ePRO, RTSM
  • Success Story
How Hinge Bio Runs Nimble Phase I Trials Without Enterprise Complexity
  • CDMS / EDC, CTMS, eCOA / ePRO, eConsent, eTMF, RTSM
  • Blog
What Medrio’s 2026 Roadmap Means for You